Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Conditions

Burkitt Lymphoma 22Lymphoma, Large B-Cell, Diffuse 19Precursor Cell Lymphoblastic Leukemia-Lymphoma 18Lymphoma, Follicular 12Lymphoma 11Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 9Rhabdomyosarcoma 8Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 7Lymphoma, B-Cell 6Leukemia, Biphenotypic, Acute 6Wilms Tumor 5Sarcoma, Ewing 5Recurrence 5Neuroblastoma 5Neoplasms 5Lymphoma, Non-Hodgkin 5Lymphoma, T-Cell 4Rhabdomyosarcoma, Embryonal 3Medulloblastoma 3Lymphoproliferative Disorders 3Lymphoma, Mantle-Cell 3Lymphoma, B-Cell, Marginal Zone 3Leukemia, Lymphocytic, Chronic, B-Cell 3Leukemia 3Down Syndrome 3Sarcoma 2Rhabdomyosarcoma, Alveolar 2Rhabdoid Tumor 2Plasmablastic Lymphoma 2Osteosarcoma 2

Interventions

Magnetic Resonance Spectroscopy 8X-Rays 6Specimen Handling 6Phantoms, Imaging 6Nuclear Medicine Department, Hospital 5Biopsy 4ulixertinib 2tipifarnib 2tazemetostat 2selpercatinib 2palbociclib 2olaparib 2lutetium Lu 177 dotatate 2larotrectinib 2ivosidenib 2erdafitinib 2ensartinib 2LY3023414 2pembrolizumab 1neratinib 1cemiplimab 1brigatinib 1Watchful Waiting 1Vincristine 1Vemurafenib 1Temozolomide 1Radiotherapy, Conformal 1Radiotherapy 1Radiation 1Platinum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Ependymoma × Vincristine × 90 days × Clear all
NCT01096368 2026-04-30

Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Ependymoma

Children's Oncology Group

Phase 3 Completed
479 enrolled 24 charts

Ependymoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡